296 related articles for article (PubMed ID: 11939887)
1. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people.
Vrancken AF; Franssen H; Wokke JH; Teunissen LL; Notermans NC
Arch Neurol; 2002 Apr; 59(4):533-40. PubMed ID: 11939887
[TBL] [Abstract][Full Text] [Related]
2. Age-Related Changes in Neurologic Examination and Sensory Nerve Amplitude in the General Population: Aging of the Peripheral Nervous System.
Taams NE; Drenthen J; Hanewinckel R; Ikram MA; van Doorn PA
Neurology; 2023 Sep; 101(13):e1351-e1358. PubMed ID: 37541844
[TBL] [Abstract][Full Text] [Related]
3. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system.
Wolfe GI
Arch Neurol; 2002 Apr; 59(4):520-2. PubMed ID: 11939885
[No Abstract] [Full Text] [Related]
4. Drug therapy for chronic idiopathic axonal polyneuropathy.
Warendorf J; Vrancken AF; van Schaik IN; Hughes RA; Notermans NC
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003456. PubMed ID: 28631805
[TBL] [Abstract][Full Text] [Related]
5. [Subclinical lesions of peripheral nervous system in multiple sclerosis patients].
Pogorzelski R; Baniukiewicz E; Drozdowski W
Neurol Neurochir Pol; 2004; 38(4):257-64. PubMed ID: 15383952
[TBL] [Abstract][Full Text] [Related]
6. Polyneuropathy associated with chronic hemodialysis: Clinical and electrophysiological study.
Ezzeldin N; Abdel Galil SM; Said D; Kamal NM; Amer M
Int J Rheum Dis; 2019 May; 22(5):826-833. PubMed ID: 30575307
[TBL] [Abstract][Full Text] [Related]
7. Medial dorsal superficial peroneal nerve studies in patients with polyneuropathy and normal sural responses.
Kushnir M; Klein C; Kimiagar Y; Pollak L; Rabey JM
Muscle Nerve; 2005 Mar; 31(3):386-9. PubMed ID: 15508123
[TBL] [Abstract][Full Text] [Related]
8. Polyneuropathy and the sural/radial sensory nerve action potential ratio in primary Sjögren's syndrome.
Eren Y; Yavasoglu NG; Ozisler C
Neurol Res; 2020 Jan; 42(1):17-21. PubMed ID: 31661424
[No Abstract] [Full Text] [Related]
9. Chronic inflammatory axonal polyneuropathy.
Oh SJ; Lu L; Alsharabati M; Morgan MB; King P
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1175-1180. PubMed ID: 32917820
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP).
Hube L; Dohrn MF; Karsai G; Hirshman S; Van Damme P; Schulz JB; Weis J; Hornemann T; Claeys KG
PLoS One; 2017; 12(1):e0170583. PubMed ID: 28114358
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperparathyroidism is associated with subclinical peripheral neural alterations.
Diniz ET; Bandeira F; Lins OG; Cavalcanti ÉN; de Arruda TM; Januário AM; Diniz KT; Marques TF; Azevedo H
Endocr Pract; 2013; 19(2):219-25. PubMed ID: 23337140
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
13. Chronic idiopathic axonal polyneuropathy: Electrophysiological progression and human leukocyte antigen associations.
Zis P; Sarrigiannis PG; Artemiadis A; Skarlatou V; Hadjivassiliou M
Muscle Nerve; 2021 Apr; 63(4):567-571. PubMed ID: 33440030
[TBL] [Abstract][Full Text] [Related]
14. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics.
Wolfe GI; Baker NS; Amato AA; Jackson CE; Nations SP; Saperstein DS; Cha CH; Katz JS; Bryan WW; Barohn RJ
Arch Neurol; 1999 May; 56(5):540-7. PubMed ID: 10328248
[TBL] [Abstract][Full Text] [Related]
15. Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity?
Ayrignac X; Viala K; Koutlidis RM; Taïeb G; Stojkovic T; Musset L; Léger JM; Fournier E; Maisonobe T; Bouche P
Muscle Nerve; 2013 Nov; 48(5):727-32. PubMed ID: 23424105
[TBL] [Abstract][Full Text] [Related]
16. Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy.
Teunissen LL; Notermans NC; Jansen GH; Banga JD; Veldman H; Wokke JH
Acta Neuropathol; 2000 Oct; 100(4):445-50. PubMed ID: 10985705
[TBL] [Abstract][Full Text] [Related]
17. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy.
Hoffman-Snyder C; Smith BE; Ross MA; Hernandez J; Bosch EP
Arch Neurol; 2006 Aug; 63(8):1075-9. PubMed ID: 16769858
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.
Koike H; Kawagashira Y; Iijima M; Yamamoto M; Hattori N; Tanaka F; Hirayama M; Ando Y; Ikeda S; Sobue G
J Neurol; 2008 Oct; 255(10):1526-33. PubMed ID: 18821042
[TBL] [Abstract][Full Text] [Related]
19. A novel sensory nerve conduction study technique to evaluate the sural nerve from the forefoot to the knee.
Zuo KJ; Lee R; Clarke NA; Dong A; Chan KM
J Clin Neurophysiol; 2015 Apr; 32(2):175-9. PubMed ID: 25761261
[TBL] [Abstract][Full Text] [Related]
20. Drug therapy for chronic idiopathic axonal polyneuropathy.
Vrancken AF; van Schaik IN; Hughes RA; Notermans NC
Cochrane Database Syst Rev; 2004; (2):CD003456. PubMed ID: 15106203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
